JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2876
BioNTech
BNTX
$24B
| $4.05M | ﹤0.01% |
26,984
+11,365
| +73% | +$1.75M |
2020 Q1
11 quarters
|
|
2877
Stevanato
STVN
$5.42B
| $4.05M | ﹤0.01% |
225,350
+75,649
| +51% | +$1.25M |
2022 Q2
2 quarters
|
|
2878
PUT
Petrobras
PBR
$153B
| $4.03M | ﹤0.01% |
378,800
+298,800
| +374% | +$3.61M |
2021 Q3
5 quarters
|
|
2879
BridgeBio Pharma
BBIO
$13.1B
| $4.03M | ﹤0.01% |
529,125
+238,841
| +82% | +$2.29M |
2019 Q2
14 quarters
|
|
2880
Usana Health Sciences
USNA
$274M
| $4.03M | ﹤0.01% |
75,779
-10,188
| -12% | -$552K |
2013 Q2
38 quarters
|
|
2881
CALL
Boston Scientific
BSX
$61.1B
| $4.03M | ﹤0.01% |
87,000
-355,100
| -80% | -$15.4M |
2021 Q1
7 quarters
|
|
2882
iShares US Healthcare Providers ETF
IHF
$1.38B
| $4.02M | ﹤0.01% |
75,085
+3,335
| +5% | +$179K |
2013 Q2
38 quarters
|
|
|
NVMI
2883
Nova
NVMI
$12.5B
| $4.02M | ﹤0.01% |
49,211
-84,435
| -63% | -$6.89M |
2018 Q3
17 quarters
|
|
2884
DraftKings
DKNG
$9.8B
| $4.01M | ﹤0.01% |
352,366
-47,887
| -12% | -$667K |
2020 Q2
10 quarters
|
|
|
CCVI
2885
DELISTED
Churchill Capital Corp VI
CCVI
| $4M | ﹤0.01% |
400,000
+120,600
| +43% | +$1.2M |
2022 Q3
1 quarter
|
|
2886
Dorchester Minerals
DMLP
$1.43B
| $4M | ﹤0.01% |
133,561
+1,003
| +0.8% | +$28.9K |
2013 Q2
38 quarters
|
|
2887
PUT
Atlassian
TEAM
$49.1B
| $3.99M | ﹤0.01% |
31,000
| – | – |
2022 Q2
2 quarters
|
|
|
KDNY
2888
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.98M | ﹤0.01% |
151,985
-164,846
| -52% | -$3.65M |
2015 Q2
30 quarters
|
|
2889
Polestar Automotive Holding UK
PSNY
$974M
| $3.98M | ﹤0.01% |
+24,992
| New | +$4.05M |
2022 Q4
0 quarters
|
|
2890
StoneCo
STNE
$2.68B
| $3.96M | ﹤0.01% |
420,016
+267,660
| +176% | +$2.8M |
2019 Q3
13 quarters
|
|
2891
U.S. High Relative Profitability Portfolio ETF Class Shares
DUHP
$12.9B
| $3.96M | ﹤0.01% |
+164,856
| New | +$3.91M |
2022 Q4
0 quarters
|
|
2892
Financial Institutions
FISI
$774M
| $3.93M | ﹤0.01% |
161,520
+4,433
| +3% | +$109K |
2013 Q2
38 quarters
|
|
2893
Global X FinTech ETF
FINX
$158M
| $3.93M | ﹤0.01% |
204,258
-21,243
| -9% | -$428K |
2019 Q2
14 quarters
|
|
|
STR
2894
DELISTED
Sitio Royalties
STR
| $3.93M | ﹤0.01% |
136,289
+129,917
| +2,039% | +$3.76M |
2019 Q1
15 quarters
|
|
2895
American Eagle Outfitters
AEO
$3B
| $3.93M | ﹤0.01% |
281,639
-24,483
| -8% | -$314K |
2013 Q2
38 quarters
|
|
2896
PUT
American Electric Power
AEP
$66.2B
| $3.93M | ﹤0.01% |
41,400
-35,200
| -46% | -$3.2M |
2018 Q4
16 quarters
|
|
2897
CALL
Archer Daniels Midland
ADM
$39.6B
| $3.93M | ﹤0.01% |
+42,300
| New | +$3.91M |
2022 Q4
0 quarters
|
|
2898
CALL
Sanofi
SNY
$94.8B
| $3.93M | ﹤0.01% |
81,100
+32,300
| +66% | +$1.42M |
2022 Q3
1 quarter
|
|
2899
PUT
Melco Resorts & Entertainment
MLCO
$1.61B
| $3.92M | ﹤0.01% |
340,700
| – | – |
2021 Q3
5 quarters
|
|
2900
Tactile Systems Technology
TCMD
$503M
| $3.92M | ﹤0.01% |
341,236
+275,704
| +421% | +$2.43M |
2017 Q4
20 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.